Millimeter Wave Radar-Based Non-Contact Cardiac Function Monitoring

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRukiye Kokkiz

About this trial

This research will develop and clinically validate a system that enables continuous and non-invasive monitoring of cardiac function in surgical patients during the pre- and post-operative periods using contactless radar sensor technology, within the scope of medical device development and clinical validation.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients scheduled for cardiovascular surgery

Patients who volunteered to participate in the study.

Disqualifiers

Patients with a body mass index <18 kg/m² or >30 kg/m²

Patients with known cardiac arrhythmias

Patients with severe pulmonary edema

Patients who wish to terminate their participation during the study period

Trial design

Design model

Single group

Treatments tested in this trial

  • Radar-based non-contact cardiac function monitoring.

    Device

    Development and clinical validation of a millimeter wave radar-based non-contact cardiac function monitoring system for preoperative and postoperative evaluation in surgical patients.

Treatment groups

30 Participants
are divided into 1 treatment group
Group A: patient monitoringOther 1 intervention

Trial outcomes

Primary outcomes

1

Monitoring patients' cardiac function with medical devices-Heart rate

The following parameter will be measured as cardiac function: Heart rate

Time frame
3 months
2

Monitoring patients' cardiac function with medical devices-Respiratory rate

The following parameter will be measured as cardiac function: Respiratory rate

Time frame
3 months
3

Monitoring patients' cardiac function with medical devices-Blood pressure

The following parameter will be measured as cardiac function: Blood pressure

Time frame
3 months
4

Monitoring patients' cardiac function with medical devices-Chest wall microvibrations

The following parameter will be measured as cardiac function: Chest wall microvibrations

Time frame
3 months

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Rukiye Kokkiz

Lead sponsor

Fenerbahce University

Sponsor institution

Health Institutes of Turkey

Collaborator

This trial is not recruiting at the moment. You can still explore other options: